35 results on '"Mitsuzuka, Koji"'
Search Results
2. PD52-10 CLINICAL SIGNIFICANCE OF THE LACDINAC-GLYCOSYLATED PROSTATE-SPECIFIC ANTIGEN ASSAY FOR PROSTATE CANCER DETECTION
3. MP74-05 OUTCOMES OF NEOADJUVANT CHEMOHORMONAL THERAPY WITH COMPLETE ANDROGEN BLOCKADE, FOLLOWED BY TREATMENT WITH DOCETAXEL AND ESTRAMUSTINE PHOSPHATE BEFORE RADICAL PROSTATECTOMY IN PATIENTS WITH HIGH-RISK LOCALIZED PROSTATE CANCER: A PROPENSITY-SCORE MATCHING ANALYSIS
4. MP37-10 ASSOCIATION OF TUMOR BURDEN WITH THE ELIGIBILITY OF UPFRONT THERAPY IN PATIENTS WITH CASTRATION NAIVE PROSTATE CANCER: A MULTICENTER RETROSPECTIVE STUDY
5. MP62-20 CLINICAL CHARACTERIZATION OF LOW PROSTATE-SPECIFIC ANTIGEN ON PROGNOSIS IN PATIENTS WITH METASTATIC CASTRATION-NAIVE PROSTATE CANCER
6. MP08-14 METABOLOMIC APPROACH TO ELUCIDATE MECHANISMS OF ACQUIRED RESISTANCE TO SUNITINIB IN RENAL CELL CARCINOMA
7. MP28-20 THE GERIATRIC NUTRITIONAL RISK INDEX AS AN INDEPENDENT PREDICTOR FOR MORTALITY IN PATIENTS WITH NEWLY DIAGNOSED METASTATIC PROSTATE CANCER: MULTICENTER RETROSPECTIVE COHORT STUDY
8. MP69-03 IMPACT OF LAPAROSCOPIC ADRENALECTOMY ON CARDIAC FUNCTION IN PATIENTS WITH PRIMARY ALDOSTERONISM
9. MP06-18 PHOSPHODIESTERASE TYPE 5 INHIBITOR ATTENUATES CHRONIC ISCHEMIA-INDUCED PROSTATIC HYPERPLASIA IN A RAT MODEL
10. MP28-09 PROGNOSTIC SIGNIFICANCE OF EARLY CHANGES IN SERUM BIOMARKER LEVELS IN PATIENTS WITH NEWLY DIAGNOSED METASTATIC PROSTATE CANCER
11. PD40-08 IMPACT OF POSITIVE SURGICAL MARGIN AND NERVE-SPARING STATUS ON BIOCHEMICAL RECURRENCE IN PATIENTS WITH PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY: A MULTICENTER RETROSPECTIVE STUDY
12. PD56-07 COMPARISON WITH DIAGNOSTIC PERFORMANCE BETWEEN ABERRANT GLYCOSYLATED S2,3PSA TEST AND CONVENTIONAL PSA TESTS
13. PD18-07 EFFECT OF TISSUE SEALING SHEETS ON ERECTILE FUNCTION FOLLOWING ROBOTIC-ASSISTED LAPAROSCOPIC PROSTATECTOMY: INTERIM RESULTS OF A RANDOMIZED CONTROLLED TRIAL
14. MP35-15 DEVELOPMENT AND VALIDATION OF A NOVEL PROGNOSTIC MODEL FOR PREDICTING OVERALL SURVIVAL IN TREATMENT NAIVE CASTRATION-SENSITIVE METASTATIC PROSTATE CANCER.
15. MP78-04 EFFICACY OF EARLY URETERAL LIGATION ON PREVENTION OF INTRAVESICAL RECURRENCE AFTER RADICAL NEPHROURETERECTOMY FOR UPPER URINARY TRACT UROTHELIAL CARCINOMA: A PROSPECTIVE SINGLE-ARM MULTICENTER CLINICAL TRIAL
16. MP52-01 DEVELOPMENT OF NEW SURGICAL DEVICE: A PIEZO-ACTUATOR PULSED WATER JET SYSTEM REDUCES RENAL DAMAGES AFTER OFF-CLAMP PARTIAL NEPHRECTOMY IN A RAT MODEL
17. PD53-08 CLINICAL IMPLICATIONS OF SERUM N -GLYCAN PROFILING AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN GERM-CELL TUMORS
18. MP37-19 SHORT-TERM IMPACT ON HEALTH-RELATED QUALITY OF LIFE OF LAPAROSCOPIC ADRENALECTOMY FOR PRIMARY ALDOSTERONISM IN JAPANESE PATIENTS
19. MP80-02 INCREASING AGE OF PATIENTS WITH TESTICULAR CANCER: 1980-2016 SINGLE-CENTER EXPERIENCE
20. MP40-01 WHO BENEFITS FROM ROBOT-ASSISTED RADICAL PROSTATECTOMY IN TERMS OF FUNCTIONAL OUTCOME?
21. MP47-20 PROSPECTIVE EVALUATION OF THE IMPACT OF TREATMENT FOR TESTICULAR CANCER ON SEXUAL FUNCTION
22. PD30-04 REASSESSMENT OF RISK FACTORS FOR BIOCHEMICAL RECURRENCE IN D’AMICO INTERMEDIATE-RISK PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY
23. MP12-06 MEDIUM-TERM OUTCOMES AFTER LAPAROSCOPIC ADRENALECTOMY FOR PRIMARY ALDOSTERONISM
24. MP12-12 DIFFERENCES BETWEEN EXTRA-ADRENAL PARAGANGLIOMAS AND PHEOCHROMOCYTOMAS IN MALIGNANT POTENTIAL
25. MP50-15 ASSOCIATION BETWEEN WEIGHT GAIN AND SARCOPENIC OBESITY IN PATIENTS WITH PROSTATE CANCER TREATED WITH ANDROGEN DEPRIVATION THERAPY
26. MP86-07 IMPACT OF TISSUE SEALING SHEET ON ERECTILE DYSFUNCTION IN A RAT MODEL OF NERVE-SPARING RADICAL PROSTATECTOMY
27. MP73-18 SARCOPENIC OBESITY ASSOCIATED WITH ANDROGEN DEPRIVATION THERAPY IN PATIENTS WITH PROSTATE CANCER
28. MP56-15 LYMPHOVASCULAR INVASION IS SIGNIFICANTLY ASSOCIATED WITH BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY EVEN IN PATIENTS WITH PT2N0 NEGATIVE RESECTION MARGIN
29. MP27-12 IMPACT OF PRE-OPERATIVE PYURIA ON OUTCOMES OF URETEROSCOPY FOR URINARY STONES
30. MP15-10 LONG-TERM QUALITY OF LIFE AFTER RADICAL PROSTATECTOMY: 8-YEAR LONGITUDINAL STUDY
31. 1939 LOW PERCENTAGE (<10%) OF POSITIVE BIOPSY CORE (PBC) IS NOT A PREDICTOR OF LOWER RISK FOR PSA RECURRENCE IN CT1C PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY IN CONTEMPORARY JAPANESE POPULATION
32. 668 CAN BIOPSY GLEASON SCORE 3+4 BE INDICATED FOR ACTIVE SURVEILLANCE CRITERIA?
33. 1931 SINGLE POSITIVE BIOPSY AND PSA LEVEL <10NG/ML WITH PROSTATE CANCER PATIENTS CAN NOT PREDICT UNILATERAL LESION IN RADICAL PROSTATECTOMY SPECIMENS IN CONTEMPORARY JAPANESE POPULATION
34. 1329 IMPACT OF BODY MASS INDEX ON CLINICOPATHOLOGICAL OUTCOME AND BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY IN JAPANESE PROSTATE CANCER PATIENTS
35. 786: Replication Competent Adenovirus,AxdAdB-3,is a Potential Therapeutics for Bladder Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.